The ability to diagnose MI was better with troponin I, but T better predicted mortality. Both tests have strengths, ...
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced data from the AMDS PERSEVERE clinical trial (the "IDE") was presented in a ...
The following is a summary of “Restrictive or Liberal Blood Transfusion in Patients with Myocardial Infarction and CKD,” ...
A new study by researchers at Karolinska Institutet and Södersjukhuset shows that advanced ultrasound imaging analyses cannot ...